Novo Nordisk launches blockbuster diabetes drug Ozempic in India

Core Insights - Danish drugmaker Novo Nordisk has launched its blockbuster diabetes drug Ozempic in India [1] Company Summary - Novo Nordisk is expanding its market presence by introducing Ozempic, a significant product in its diabetes portfolio, to the Indian market [1] Industry Summary - The launch of Ozempic in India highlights the growing demand for diabetes treatments in the region, indicating potential market growth opportunities for pharmaceutical companies [1]